Key facts
- This page summarizes Christopher Min Fang Wang's Form 4 filing for STAAR SURGICAL CO (STAA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2026, 16:11.
Christopher Min Fang Wang - 18 Jun 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Reporting relationship
- Director
- Issuer ticker
- STAA
- Reported as of
- 18 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2026, 16:11:48 UTC
- Prior SEC filing
- 10 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Min Fang Wang
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher Min Fang Wang filed Form 4 for STAAR SURGICAL CO (STAA) on 23 Jun 2026.
Change
- Previous filing in this sequence was filed on 10 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002110712
Primary reporting owner
Wang Christopher Min Fang
- Relationship
- Director
- Address
- UNIT 3703, 37/F AIA TOWER, 183 ELECTRIC ROAD, NORTH POINT, HONG KONG, HONG KONG
- Signature
- /s/ Christopher Min Fang Wang
- Signature date
- 23 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STAA
transaction
Derivative
Common Stock Option
Award
- Transaction value
- Shares
- +11,145
- Change %
- Price
- $0.000000*
- Shares after
- 11,145
- Date
- 18 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 11,145
- Exercise price
- $29.12
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Award of stock options granted to the Reporting Person on June 18, 2026. These stock options will vest in full on the earlier of June 18, 2027 or the Issuer's 2026 annual meeting of shareholders.